IL-10 response in mice receiving anti-IL-22 after the onset of arthritis is not significantly different from mice receiving isotype control suggesting that IL-22 mediated modulation of IL-10 is dependent on the overall level of inflammation: being blunted in the presence of high levels of inflammation. The gene discussed is IL10; the disease is arthritic joint disease.